Table 1 Baseline characteristics of patients’ blood test results. Stratified by time of death within, 3, 10, 30, and 365 days after admission at the emergency department.
Total | Survival | 3-day mortality | 10-day mortality | 30-day mortality | 365-day mortality | |
|---|---|---|---|---|---|---|
Number of patients | 28,671 | 23,039 | ||||
Mortality rate (%) | 5632 (19.6%) | 0 | 201 (0.7%) | 1252 (4.4%) | 2338 (8.2%) | 4677 (16.3%) |
Variables | ||||||
Age | 65.6 (48.2: 78.5) | 54.7(38.0: 70.0) | 80.6 (71.5: 87) | 80.8 (71.7: 88.2) | 80.4 (71: 87.7) | 79.1 (69.5: 86.5) |
Sex (female) | 15,175 (52.9%) | 1231 (53.4%) | 184 (51.8%) | 668 (52%) | 1376 (51.5%) | 4224 (49%) |
ALAT (U/L) | 21 (15: 33) | 22 (16: 33) | 31 (19: 82) | 25 (16: 52) | 22 (15: 41) | 19 (13: 32) |
Albumin (g/L) | 34 (30: 37) | 36(33: 36) | 27 (22: 31) | 27 (22: 31) | 27 (22: 31) | 29 (25: 33) |
Basophils (× 10^9 /L) | 0.03 (0.02: 0.05) | 0.03(0.02: 0.05) | 0.03 (0.02: 0.05) | 0.03 (0.01: 0.05) | 0.03 (0.01: 0.05) | 0.03 (0.02: 0.05) |
Alkaline Phosphatase (U/L) | 76 (63: 94) | 69 (56: 85.8) | 123 (90: 176) | 114 (83: 152) | 114 (82: 149) | 98 (75: 129) |
Bilirubin (µmol/L) | 7 (5: 10) | 7 (6: 10) | 9 (6: 17) | 10 (6: 16) | 9 (6: 14) | 8 (5: 13) |
BUN (mmol/L) | 5.1 (3.8: 7.2) | 4.7 (3.5: 6) | 11.5 (7.1: 19.5) | 10.8 (6.7: 17.4) | 9.6 (6.1: 15.8) | 7.6 (5.1: 12.3) |
Creatinine (µmol/L) | 77 (62: 97) | 74 (62:89) | 123 (82: 190) | 107 (72: 171) | 98 (67: 153) | 90 (66: 132) |
CRP (mg/L) | 7 (2: 39) | 4 (1:19) | 76 (20.5: 180) | 73 (27: 160) | 67 (22: 148.5) | 38 (9: 95) |
HB (mmol/L) | 8.1 (7.2: 8.9) | 8.4 (7.7–9.1) | 7.3 (6.3: 8.5) | 7.2 (6.2: 8.3) | 7.1 (6.2: 8.1) | 7.2 (6.3: 8.1) |
INR | 1 (1: 1.1) | 1 (1: 1.1) | 1.2 (1: 1.4) | 1.1 (1: 1.3) | 1.1 (1: 1.3) | 1.1 (1: 1.2) |
Potassium (mmol/L) | 3.9 (3.6: 4.2) | 3.8 (3.6: 4.1) | 4.3 (3.8: 5.1) | 4.1 (3.6: 4.6) | 4 (3.6: 4.5) | 4 (3.6: 4.3) |
KF2710 | 0.91 (0.77: 1.02) | 0.92 (0.77: 1.01) | 0.74 (0.55:0.89) | 0.76 (0.56: 0.91) | 0.77 (0.58: 0.91) | 0.83 (0.66: 0.96) |
LDH (U/L) | 186 (169: 214) | 175 (151:205) | 334 (267: 410) | 289 (229: 355) | 268 (219: 328) | 224(188: 274) |
Leukocytes (× 10^9 /L) | 8.7 (6.9: 11.3) | 8.5 (6.9: 10.8) | 13.7 (9.6: 19.6) | 12.7 (9.1: 17.0) | 11.8 (8.6: 16.0) | 10.1 (7.6: 13.8) |
Lymphocytes (× 10^9 /L) | 1.7 (1.1: 2.3) | 1.8 (1.3: 2.5) | 1.2 (0.7: 1.9) | 1 (0.6: 1.6) | 1.1 (0.7: 1.6) | 1.2 (0.8: 1.8) |
MCHC (mmol/L) | 20.7 (20.1: 21.2) | 20.9 (20.4: 21.4) | 19.8 (19.1:20.5) | 20 (19.3: 20.6) | 20 (19.4: 20.7) | 20.2 (19.5: 20.8) |
MCV (fL) | 89 (86: 93) | 88 (85: 92) | 93 (88: 98) | 92 (87: 97) | 91 (87: 96) | 91 (87: 95) |
Monocytes (× 10^9 /L) | 0.7 (0.5: 0.9) | 0.6 (0.5: 0.8) | 0.8 (0.5: 1.3) | 0.8 (0.5: 1.16) | 0.8 (0.51: 1.1) | 0.8 (0.53: 1.02) |
Neutrocytes (× 10^9 /L) | 5.8 (4.1: 8.3) | 5.4 (4.: 7.6) | 10.9 (7.4: 15.4) | 10.3 (6.9: 14.2) | 9.5 (6.4: 13.4) | 7.6 (5.3: 11.2) |
Promm (× 10^9 /L) | 0.03 (0.02: 0.06) | 0.03 (0.02: 0.05) | 0.11 (0.05: 0.29) | 0.09 (0.04: 0.19) | 0.08 (0.04: 0.16) | 0.05 (0.03: 0.11) |
suPAR (ng/ml) | 3.3 (2.3: 5.0) | 2.6 (1.9–3.6) | 7.3 (5.2: 10.8) | 7.0 (4.9: 10.2) | 6.7 (4.7: 9.7) | 5.7 (4.0: 8.2) |
Thrombocytes (× 10^9/L) | 247 (201: 302) | 242 (201: 292) | 266 (196: 350) | 259 (193: 350) | 266 (200: 354) | 260 (199: 338) |
Eosinophils (× 10^9 /L) | 0.11 (0.04: 0.19) | 0.11 (0.04: 0.21) | 0.01 (0: 0.05) | 0.01 (0: 0.07) | 0.028 (0: 0.10) | 0.07 (0.01: 0.17) |
eGFR (mL/min) | 80 (60: 90) | 87 (70: 90) | 42 (25: 69) | 51 (29: 77) | 56 (34: 83) | 62 (40: 86) |
Sodium (mmol/L) | 139 (136: 141) | 139 (137: 141) | 138 (134: 142) | 138 (134: 142) | 138 (134: 142) | 138 (135: 141) |
